Trading at a forward price-to-earnings (P/E) ratio of more than 150 times 2025 analyst estimates, Tesla's valuation still ...

Lilly takes POINT in radiopharma push Eli Lilly has made a foray into the radiopharmaceuticals category with an agreement to buy POINT Biopharma for around $1.4 billion.

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare professionals prescribing the drug, accounting for around 45% of the ...

Motivating yourself is one of the main things that sets high achievers apart, and it’s hard. How do you keep pushing onward when your heart isn’t in it? In her research, Fishbach has ...

My boyfriend is having the same problems as most of you, but on the Smart Start In-Home Device. Last month, it said he missed 3 blows and was late on ...